Evidence map›Paper›PMID 40078200›Full record

ArticleJournal of clinical and translational hepatology2025

Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis (2024).

Xiaoyuan Xu, Huiguo Ding, Wengang Li, Ying Han, Yujuan Guan, Jinghang Xu, Yifan Han, Jidong Jia, Lai Wei, Zhongping Duan and 3 more

Abstract read
In one paragraph

Article in Journal of clinical and translational hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. [Chinese guidelines for clinical diagnosis, treatment, and management of cirrhosis (2025)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Guideline
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xiaoyuan XuDepartment of Gastroenterology, Peking University First Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-1759-4330
Huiguo DingHepatology and Gastroenterology Center, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Wengang LiComprehensive Liver Cancer Center, The Fifth Medical Center of the People's Liberation Army General Hospital, Beijing, China.
Ying HanHepatology and Gastroenterology Center, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Yujuan GuanHepatology Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Jinghang XuDepartment of Gastroenterology, Peking University First Hospital, Beijing, China.
Yifan HanDepartment of Gastroenterology, Peking University First Hospital, Beijing, China.
Jidong JiaHepatology Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Lai WeiHepatobiliary and Pancreatic Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Zhongping DuanHepatology Center, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Yuemin NanDepartment of Integrated Traditional Chinese and Western Medicine Hepatology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Hui ZhuangDepartment of Pathogenic Biology, Peking University Health Science Center, Beijing, China.
Chinese Society of Hepatology, Chinese Medical Association

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With progress in basic and clinical research on hepatic encephalopathy in cirrhosis worldwide, the Chinese Society of Hepatology of the Chinese Medical Association has invited experts in relevant fields to revise the 2018 "Chinese Guidelines on the Management of Hepatic Encephalopathy in Cirrhosis." The updated guidelines provide recommendations for the clinical diagnosis, treatment, and both primary and secondary prevention of hepatic encephalopathy in cirrhosis.

Indexed as

DiagnosisGuidelinesHepatic encephalopathyLiver cirrhosisMinimal hepatic encephalopathyPreventionTherapy

Identifiers

PMID40078200
PMCPMC11894390

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.